CVS Health Corporation is rated a Buy with a strong turnaround driving industry-leading results. Learn more about CVS stock ...

CVS is a strong buy now, with rising earnings, solid dividends, and steady growth prospects despite industry challenges. Read ...

CVS Health is gradually implementing changes that will help it put the weak bottom-line performances of the past few years ...

CVS Health (CVS) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider ...

CVS Health ( CVS 1.57%) has been a huge outperformer this year. The stock is up about 79% so far in 2025 -- move than five ...

We recently published 10 Stocks Boasting 10-42% Gains. TeraWulf Inc. (NASDAQ:WULF) is one of the best-performing stocks on Tuesday. TeraWulf rallied for a second day on Tuesday, jumping 10.37 percent ...

Nvidia Corp. increased sales by 62% in its latest quarter, and analysts see more revenue momentum ahead. But investors looking for fast growth in the chip sector have a number of places to look beyond ...

RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its “RiverPark Large Growth Fund” Q3 2025 investor letter. A copy of the letter can be ...

Also Read: Eli Lilly's Investigational Obesity Drug Shows Up To 20% Weight Loss In Phase 2 Study, Analyst Sees It As Emerging Cornerstone In Obesity Treatment In March, Novo Nordisk launched NovoCare ...

WATERBURY, CT (WFSB) - Gov. Ned Lamont announced Tuesday a final agreement between UConn Health and Prospect Medical Holdings to sell Waterbury Hospital to the state. The deal involves $13 million in ...

Current CVS Health CEO David Joyner took over a little over a year ago. The company's growth rate has been improving and its overall financial results have been stronger. The stock's rally has put it ...